[go: up one dir, main page]

MX2019015673A - Composicion de granulos veterinarios que contiene extracto de ca?amo. - Google Patents

Composicion de granulos veterinarios que contiene extracto de ca?amo.

Info

Publication number
MX2019015673A
MX2019015673A MX2019015673A MX2019015673A MX2019015673A MX 2019015673 A MX2019015673 A MX 2019015673A MX 2019015673 A MX2019015673 A MX 2019015673A MX 2019015673 A MX2019015673 A MX 2019015673A MX 2019015673 A MX2019015673 A MX 2019015673A
Authority
MX
Mexico
Prior art keywords
extract
veterinary
amo
composition
granules containing
Prior art date
Application number
MX2019015673A
Other languages
English (en)
Inventor
Halperin Wernli Miriam
Wernli Jorge
Batista Trepp Gian
Huber Silvia
Madea Franco
Original Assignee
Creso Pharma Switzerland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Creso Pharma Switzerland Gmbh filed Critical Creso Pharma Switzerland Gmbh
Publication of MX2019015673A publication Critical patent/MX2019015673A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3482—Cannabis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Las composiciones veterinarias o los suplementos dietéticos o alimenticios son útiles en la prevención o el tratamiento de trastornos de comportamiento, que se relacionan respectivamente con la edad, problemas y dolores en mamíferos. También son para apoyar o fortalecer el sistema inmune, el equilibrio conductual de los mamíferos y para apoyar la respuesta inflamatoria natural. Estas composiciones o suplementos están en forma de gránulos a base de polisacáridos solubles en agua que comprenden como fuente de canabinoides un aceite o extracto estandarizado de cáñamo (Cannabis sativa L.) esencialmente desprovisto de sustancias psicotrópicas.
MX2019015673A 2017-06-30 2018-06-25 Composicion de granulos veterinarios que contiene extracto de ca?amo. MX2019015673A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762527463P 2017-06-30 2017-06-30
PCT/IB2018/000707 WO2019002933A1 (en) 2017-06-30 2018-06-25 VETERINARY GRANULAR COMPOSITION CONTAINING HEMP EXTRACT

Publications (1)

Publication Number Publication Date
MX2019015673A true MX2019015673A (es) 2020-02-26

Family

ID=63042061

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019015673A MX2019015673A (es) 2017-06-30 2018-06-25 Composicion de granulos veterinarios que contiene extracto de ca?amo.

Country Status (5)

Country Link
EP (1) EP3645119A1 (es)
BR (1) BR112019026635A2 (es)
CO (1) CO2020000111A2 (es)
MX (1) MX2019015673A (es)
WO (1) WO2019002933A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
CA3089994A1 (en) 2018-01-31 2019-08-08 Canopy Holdings, LLC Hemp powder
EP3820530A4 (en) * 2018-07-10 2022-03-30 Cardinal Advisory Limited FORMULATION OF CANNABINOID COMPOUNDS
US11040932B2 (en) 2018-10-10 2021-06-22 Treehouse Biotech, Inc. Synthesis of cannabigerol
CN111978417B (zh) * 2019-09-06 2021-08-06 云南汉盟制药有限公司 一种大麻多糖的提取方法及其产品和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007046086A1 (de) * 2007-09-26 2009-04-09 Heinz Prof. Dr. Letzel Pflanzenextrakt aus THC-armen Cannabis zur Behandlung von Erkrankungen
JP2018505912A (ja) * 2014-12-12 2018-03-01 オーハイ エナジェティクス ピービーシー マイクロカプセル化カンナビノイド組成物

Also Published As

Publication number Publication date
BR112019026635A2 (pt) 2020-06-30
EP3645119A1 (en) 2020-05-06
CO2020000111A2 (es) 2020-01-17
WO2019002933A1 (en) 2019-01-03

Similar Documents

Publication Publication Date Title
CO2020000111A2 (es) Composición de gránulos veterinarios que contiene extracto de cáñamo
CL2020000632A1 (es) Composición y método para el tratamiento del autismo.
CL2017002998A1 (es) Plantas que tienen expresión modificada de thca sintasa
CO2019001043A2 (es) Composición de cannabis
CL2020003368A1 (es) Composicion y metodo para tratar el dolor
CL2018000829A1 (es) Anticuerpos anti-cd19 humano con alta afinidad
BR112017025339A2 (pt) composições nutricionais contendo um nível elevado de inositol e usos das mesmas
PE20200338A1 (es) Composiciones cannabinoides novedosas y metodos para tratar la epilepsia infantil
CL2020003373A1 (es) Composición y método de ahorro de opiáceos
CO2019000787A2 (es) Nuevas formulaciones y composiciones de cannabis en comprimidos y métodos para su elaboración
MX2021015256A (es) Mezcla de extractos vegetales para el uso en la prevención y/o tratamiento de enfermedades intestinales inflamatorias crónicas.
CO2019007902A1 (es) Sistemas y métodos para mejorar la formación y densidad de tricomas en cannabis
MX2015011255A (es) Composicion a base de flavonoides para uso farmaceutico, nutricional o cosmetico que tiene accion antioxidante potenciada.
CO2021002085A2 (es) Composiciones de curcuminoides
BR112015020365A2 (pt) fração bioativa derivada de fruta, composição, e método para isolar uma fração bioativa
CL2020003374A1 (es) Composicion y metodo de cannabinoides para tratar el tept y/o la ansiedad
KR102403795B9 (ko) 헴프씨드 추출물을 포함하는 항알레르기성 또는 항산화용 조성물
CL2017002967A1 (es) Beta-caseinas a2 y capacidad antioxidante.
EA201991659A1 (ru) Композиция от кашля
MA40645A (fr) Préparation prébiotique à base d'inuline
EA201790622A1 (ru) Терапевтические и питательные композиции для функциональных нарушений работы пищеварительной системы
MX2019006547A (es) Composiciones sólidas en polvo, proceso para su preparación, formulaciones y uso de las mismas.
EA201890479A1 (ru) Гидрофобный гель на основе витамина е без продуктов силикона для местного применения
PL413074A1 (pl) Preparat ziołowy i zastosowanie
BR112017028373A2 (pt) composições de lubrificantes compreendendo grupos funcionais de diol e métodos de fabricá-los e utilizá-los